Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

glyBURIDE-metFORMIN

glyBURIDE-metFORMIN
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Glucovance TABLET, ORAL 1.25 mg-250 mg, 2.5 mg-500 mg, 5 mg-500 mg    
Comments:

ORDER FORMULATION

THERAPEUTIC INTERCHANGE

glyburide-metFORMIN (Glucovance)

  • 1.25 mg-250 mg tablet                                                        
  • 2.5 mg-500 mg tablet                                                              
  • 5 mg-500 mg tablet oral

glipizide (Glucotrol) AND metFORMIN (Glucophage)

  • 2.5 mg glipiZIDE tablet PLUS 250 mg (1/2 of 500 mg IR) metFORMIN tablet 
  • 5 mg glipiZIDE tablet PLUS ONE 500 mg metFORMIN tablet
  • 10 mg glipiZIDE tablet PLUS ONE 500 mg metFORMIN tablet

 

Non-formulary.  Interchange to individual components. If ordered as no substitution, dispense glyburide and metformin as separate products.

 

 

metFORMIN -- hold for 48 hours post IV contrast media per radiologist, contraindications with CHF, renal disease, hepatic disease, and age. Pharmacist may order SCr.

 

Updated: August 2024

Glyburide_metformin (GLUCOVANCE) August 2024 Update (2).pdf

Last updated: Dec. 24, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved